Whole recombinant Pichia pastoris expressing HPV16 L1 antigen is superior in inducing protection against tumor growth as compared to killed transgenic Leishmania

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers

(2013) Sahar Hosseinzadeh et al.   DRUG DELIVERY

Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies

(2013) Shailendra Mani et al.   PLoS One

Killed but metabolically active vaccines

(2012) Thomas W Dubensky et al.   CURRENT OPINION IN BIOTECHNOLOGY

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model

(2012) Maryam Salehi et al.   Immunotherapy

Therapeutic live vaccines as a potential anticancer strategy

(2012) Azam Bolhassani et al.   INTERNATIONAL JOURNAL OF CANCER

Virus‑like particles as a vaccine delivery system: Myths and facts

(2011) Polly Roy et al.   Human vaccines & immunotherapeutics

Fluorescent Leishmania species: Development of stable GFP expression and its application for in vitro and in vivo studies

(2010) Azam Bolhassani et al.   EXPERIMENTAL PARASITOLOGY

Subcutaneous immunization against Leishmania major - infection in mice: efficacy of formalin-killed promastigotes combined with adjuvants

(2010) Joshua M. Mutiso et al.   REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO

A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer

(2010) Alejandrina Vendrell et al.   VACCINE

Expression and characterization of HPV-16 L1 capsid protein in Pichia pastoris

(2009) Silvia Boschi Bazan et al.   ARCHIVES OF VIROLOGY

Recombinant Protein Expression in Leishmania tarentolae

(2009) Giancarlo Basile et al.   MOLECULAR BIOTECHNOLOGY

Inoculation of killed Leishmania major into immune mice rapidly disrupts immunity to a secondary challenge via IL-10-mediated process

(2009) I. Okwor et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The production of recombinant human laminin-332 in a Leishmania tarentolae expression system

(2009) Hoang-Phuong Phan et al.   PROTEIN EXPRESSION AND PURIFICATION

Qualitative differences in the early immune response to live and killed Leishmania major: Implications for vaccination strategies against Leishmaniasis

(2009) Ifeoma Okwor et al.   VACCINE

Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses

(2009) Guanglin Bian et al.   VACCINE

Immunogenicity of an HPV-16 L2 DNA vaccine

(2009) Inga I. Hitzeroth et al.   VACCINE

Saccharomyces cerevisiae as a vaccine against coccidioidomycosis

(2009) Javier Capilla et al.   VACCINE

Recombinant proprotein convertase 4 (PC4) from Leishmania tarentolae expression system: Purification, biochemical study and inhibitor design

(2008) Ajoy Basak et al.   PROTEIN EXPRESSION AND PURIFICATION

Vaccination with HPV16 L2E6E7 fusion protein in GPI-0100 adjuvant elicits protective humoral and cell-mediated immunity

(2008) Balasubramanyam Karanam et al.   VACCINE

Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells

(2007) Michael B. Bernstein et al.   VACCINE